TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
RAPP

Rapport Therapeutics, Inc.

Healthcare · Biotechnology

33.80$ -0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Rapport Therapeutics, Inc. (RAPP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 459 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RAPP
Line item Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 155 206 346 331 315 302 285 535 512 498 459
– – – 151 199 341 326 310 291 270 521 499 485 447
– – – 70 74 110 39 57 58 55 251 53 78 64
– – – 147 193 336 321 305 285 260 513 491 477 436
– – – – – – – – – – – – 0.1 0.3
– – – 181 246 9.2 8.0 9.5 16 22 24 28 26 36
– – – 8.8 9.9 8.1 7.1 8.8 9.4 12 14 19 18 28
– – – 0.7 0.7 0.7 0.7 0.7 1.0 1.8 2.5 2.8 2.6 2.5
– – – 2.5 1.4 1.9 1.3 2.0 2.1 3.2 3.2 4.2 6.6 2.8
– – – -26 -40 337 323 305 286 264 512 485 472 423
– – – -45 -68 -86 -104 -124 -148 -175 -201 -235 -255 -312
19 20 19 18 19 20 19 19 19 35 38 47 47 47

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?